These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34569452)

  • 41. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T; Furuoka H; Muroi Y; Nishimura M
    J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-dengue infectivity evaluation of bioflavonoid from
    Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
    J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.
    Bustanji Y; Taha MO; Almasri IM; Al-Ghussein MA; Mohammad MK; Alkhatib HS
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):771-8. PubMed ID: 18720192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer's Disease: Stereochemistry and Biological Activity.
    Hu XL; Guo C; Hou JQ; Feng JH; Zhang XQ; Xiong F; Ye WC; Wang H
    ACS Chem Neurosci; 2019 Feb; 10(2):996-1007. PubMed ID: 29944335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
    Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
    J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
    Yue H; Lu F; Shen C; Quan JM
    Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review.
    Xu M; Wang SL; Zhu L; Wu PY; Dai WB; Rakesh KP
    Eur J Med Chem; 2019 Feb; 164():448-470. PubMed ID: 30616053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.
    Lin CH; Hsieh YS; Wu YR; Hsu CJ; Chen HC; Huang WH; Chang KH; Hsieh-Li HM; Su MT; Sun YC; Lee GC; Lee-Chen GJ
    Eur J Pharm Sci; 2016 Jun; 89():11-9. PubMed ID: 27094783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allosteric regulation of glycogen synthase kinase 3β: a theoretical study.
    Buch I; Fishelovitch D; London N; Raveh B; Wolfson HJ; Nussinov R
    Biochemistry; 2010 Dec; 49(51):10890-901. PubMed ID: 21105670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders.
    Iqbal D; Alsaweed M; Jamal QMS; Asad MR; Rizvi SMD; Rizvi MR; Albadrani HM; Hamed M; Jahan S; Alyenbaawi H
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.
    Li X; Bijur GN; Jope RS
    Bipolar Disord; 2002 Apr; 4(2):137-44. PubMed ID: 12071511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro.
    Cordes N; van Beuningen D
    Br J Cancer; 2003 May; 88(9):1470-9. PubMed ID: 12778079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
    Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
    Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of inhibitors of glycogen synthase kinase-3β from traditional Chinese medicines using enzyme-immobilized magnetic beads combined with high-performance liquid chromatography.
    Li Y; Xu J; Chen Y; Mei Z; Xiao Y
    J Chromatogr A; 2015 Dec; 1425():8-16. PubMed ID: 26610618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.
    Liu W; Tian L; Wu L; Chen H; Wang N; Liu X; Zhao C; Wu Z; Jiang X; Wu Q; Xu Z; Liu W; Zhao Q
    Bioorg Chem; 2022 Dec; 129():106168. PubMed ID: 36191431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.